Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07367958
PHASE1
A Study to Compare the Auto-injector and Pre-filled Syringe of CT-P52 in Healthy Male Subjects
Sponsor: Celltrion
View on ClinicalTrials.gov
Summary
This is phase 1 study to Compare the Pharmacokinetics, Safety and Immunogenicity of the Auto-injector and Pre-filled syringe of CT-P52 in Healthy Male Subjects.
Official title: A Phase 1, Randomized, Open-label, Two-arm, Parallel-Group, Single-dose Study to Compare Pharmacokinetics and Safety of CT-P52 AI and CT-P52 PFS in Healthy Male Subjects
Key Details
Gender
MALE
Age Range
19 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
218
Start Date
2026-01
Completion Date
2027-01
Last Updated
2026-01-26
Healthy Volunteers
Yes
Conditions
Interventions
BIOLOGICAL
CT-P52
CT-P52, 80 mg in 1 ml, a single subcutaneous (SC) injection via auto-injector (AI)